Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder-Reference-Cited by-同舟云学术

Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder

Published:2022-06 Issue:3 Volume:18 Page:351.e1-351.e8
ISSN:1477-5131
Container-title:Journal of Pediatric Urology
language:en
Short-container-title:Journal of Pediatric Urology

Author:

Lambregts Annemarth P.,Nieuwhof-Leppink Anka J.,Klijn Aart J.,Schroeder Rogier P.J.

Publisher

Elsevier BV

Subject

Urology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society;Austin;Neurourol Urodyn,2016

2. Overactive bladder in children;Franco;Nat Rev Urol,2016

3. Daytime urinary incontinence in children and adolescents;Nieuwhof-Leppink;Lancet Child Adolesc Health,2019

4. Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children's Continence Society (ICCS);Nieuwhof-Leppink;J Pediatr Urol,2020

5. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program;Meijer;J Pediatr Urol,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder and Bowel Dysfunction: An Updated Guide for the Pediatrician and Pediatric Nephrologist;Current Pediatrics Reports;2024-08-31

2. Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder;Journal of Pediatric Urology;2024-08

3. Use and Outcomes of Botulinum Toxin A for Both Neurogenic and Non-neurogenic Voiding Dysfunction in the Pediatric Patient;Current Bladder Dysfunction Reports;2024-02-06

4. Treatment modalities for paediatric functional daytime lower urinary tract disorders: an updated review;Therapeutic Advances in Urology;2024-01

5. An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity;Expert Review of Neurotherapeutics;2023-08-15